Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Prior to Abdominal Operation: a Retrospective Analysis by Schmitz, Adam et al.
Preoperative TIPS 1 
Transjugular intrahepatic portosystemic shunt (TIPS) creation prior to abdominal operation: a 1 
retrospective analysis 2 
Adam Schmitz, Paul Haste, MD, Matthew S. Johnson, MD3 
Indiana University School of Medicine, Department of Radiology 4 
550 N University Blvd Indianapolis, IN 46202 5 
6 
Adam Schmitz 7 
7424 Samuel Drive Indianapolis, IN 46259 8 
Phone: 260-433-4955 9 
Fax: N/A 10 
Email: awschmit@iupui.edu 11 
12 
Dr. Paul Haste 13 
Indiana University School of Medicine, Department of Radiology 14 
550 N. University Blvd Indianapolis, IN 46202 15 
Phone: 317-944-5005 16 
Fax: N/A 17 
Email: phaste@iupui.edu 18 
19 
Dr. Matthew S. Johnson 20 
3Indiana University School of Medicine, Department of Radiology 21 
550 N. University Blvd Indianapolis, IN 46202 22 
Phone: 317-948-0849 23 
Fax: N/A 24 
Email: matjohns@iupui.edu 25 
26 
Support 27 
NIH T35 Research Fellowship 28 
29 
____________________________________________________
This is the author's manuscript of the article published in final edited form as: 
Schmitz, A., Haste, P., & Johnson, M. S. (2019). Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Prior to Abdominal 
Operation: A Retrospective Analysis. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the 
Alimentary Tract. https://doi.org/10.1007/s11605-019-04384-w
Preoperative TIPS 2 
Conflicts of Interest 30 
Adam Schmitz: None declared 31 
Dr. Paul Haste: None declared 32 
Dr. Matthew S. Johnson: Dr. Johnson is a paid consultant to Cook Medical 33 
34 
Previous Presentations 35 
This paper was presented in abstract form at the Society of Interventional Radiology 2019 36 
Annual Scientific Meeting, Austin, TX March 25 2019 37 
38 
Authorship 39 
Adam Schmitz made substantial contributions to the design of this study, analyzed the data, and 40 
wrote and approved the final manuscript form. In addition Mr. Schmitz agrees to be accountable 41 
for the information presented in this manuscript. 42 
Dr. Paul Haste made substantial contributions to the design of this study, aided in the drafting 43 
process, and approved the final manuscript form. In addition Dr. Haste agrees to be accountable 44 
for the information presented in this manuscript. 45 
Dr. Matthew S. Johnson made substantial contributions to the design of this study, aided in the 46 
drafting process, and approved the final manuscript form. In addition Dr. Johnson agrees to be 47 
accountable for the information presented in this manuscript. 48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
Preoperative TIPS 3 
Purpose: Transjugular intrahepatic portosystemic shunt (TIPS) creation is most commonly 58 
performed for patients with refractory ascites or variceal hemorrhage. While TIPS have also been 59 
created prior to planned abdominal operation to decrease morbidity related to portal 60 
hypertension, there are limited data supporting its effectiveness in that indication. The goal of 61 
this study was to determine if preoperative TIPS creation allows for successful abdominal 62 
operation with limited morbidity. 63 
Methods: A retrospective review of records of 22 consecutive patients who underwent TIPS 64 
creation for the specific indication of improving surgical candidacy, between 2011 and 2016, 65 
was performed. Clinical and serologic data were obtained for 21 patients (one patient was 66 
excluded since she was completely lost to follow up after TIPS creation). The primary endpoint 67 
was whether patients underwent planned abdominal operation following TIPS. Operative 68 
outcomes and reasons that patients failed to undergo planned operation were examined as 69 
secondary endpoints. The mean age was 56.4 ± 8.8 years, and the mean Child-Pugh and Model 70 
for End-Stage Liver Disease (MELD) scores were 7.2 ± 1.5 and 11.9 ± 4.3, respectively.  71 
Results: TIPS creation was performed in all 21 patients with a thirty-day mortality rate of 9.5%.  72 
Eleven patients (52.4%) subsequently underwent abdominal operation after which the thirty-day 73 
postoperative mortality rate was 0%. One patient (9.1%) had major perioperative morbidity 74 
related to portal hypertension and presented with surgical wound dehiscence and infection 75 
requiring drain placement and antibiotic therapy.  76 
Conclusions: In this population, TIPS allowed successful abdominal operation in the majority of 77 
patients, with thirty-day TIPS mortality of 9.5%, no perioperative mortality, and 9.1% major 78 
postoperative morbidity attributable to portal hypertension. 79 
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Introduction 81 
Transjugular intrahepatic portosystemic shunt (TIPS) creation is most commonly 82 
performed for one of two indications: variceal hemorrhage or refractory ascites [1]. A third 83 
indication that may lead to TIPS creation is portal decompression prior to planned abdominal 84 
operation. Cirrhosis is a widely recognized predictor of operative morbidity and mortality, with a 85 
recent systematic review indicating that cirrhotic patients undergoing any surgical procedure 86 
have postoperative morbidity and thirty-day mortality rates of 30.1% and 11.6%, respectively 87 
[2]. Patients with cirrhosis and concomitant portal hypertension have even greater operative 88 
risks, which can be accurately assessed by Child-Pugh and model for end-stage liver disease 89 
(MELD) scores [2, 3]. One recent study found that patients with portal hypertension undergoing 90 
gastrointestinal surgery had a 6-fold increase in 30-day mortality rates compared to patients 91 
without portal hypertension [4]. Some studies have indicated that portal decompression via 92 
neoadjuvant TIPS can ameliorate operative risks and improve outcomes, while others describe 93 
no benefit [5, 6, 7]. Definitive answers have been difficult to pinpoint due to the relative 94 
infrequency of this indication for TIPS and the small sample sizes in the published literature. In 95 
addition, the practicality of using TIPS to facilitate abdominal operation has yet to be examined 96 
in the United States where non-alcoholic fatty liver disease (NAFLD) is the most common cause 97 
of liver disease [8]. The goal of this study was to determine the percentage of patients who 98 
underwent abdominal operation following preoperative TIPS creation and to understand the 99 
relationship between preoperative TIPS and perioperative outcomes.  100 
Materials and Methods 101 
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This retrospective study was conducted at a single university medical center, was HIPAA 102 
compliant and approved by the institutional review board. Patients who underwent TIPS creation 103 
between 2011-2016 were identified through a database search, and these patients were further 104 
stratified by indication for TIPS. Twenty-two patients underwent TIPS creation with the specific 105 
goal of improving surgical candidacy. One patient for whom no follow up data were available 106 
was excluded, yielding a final cohort of 21 patients. 107 
Clinical and serologic data were collected for all patients. Patient demographics, liver 108 
disease etiology, laboratory values, and physiologic measurements were recorded. Medical 109 
history including the presence of varices, ascites, and encephalopathy was also taken into 110 
consideration. Liver function was assessed using MELD and Child-Pugh scores. Clinical and 111 
serologic data for all patients prior to TIPS is summarized in Table 1.  112 
All patients had manifestations of portal hypertension prior to TIPS (varices, ascites, or 113 
both). Patients were referred for TIPS creation specifically to improve their surgical candidacy 114 
through decompression of varices (n=11) or reduction of ascites (n=10). Seven of these patients 115 
did not have a history of variceal bleeding, but rather had varices noted on pre-operative 116 
imaging. The planned abdominal operations included hernia repair (n=10), sleeve gastrectomy 117 
(n=6), cholecystectomy (n=1), gastrectomy (n=1), esophagectomy (n=1), renal transplant (n=1), 118 
and colectomy (n=1). Most of the operations planned to use an open approach (n=15), but 119 
several operations were to be carried out using laparoscopic methods (n=6). 120 
Records of patients undergoing the planned abdominal operation after TIPS were 121 
examined for perioperative complications, and these were then divided into those related to 122 
portal hypertension (ascites, variceal bleeding, etc.) and those that were unrelated. All of these 123 
perioperative complications were then included in this study.  124 
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The primary endpoint was whether patients underwent the planned abdominal operation 125 
after TIPS, with failure simply being defined as not proceeding to the planned abdominal 126 
operation. Reasons for failure to undergo the operation and outcomes of TIPS and abdominal 127 
operation were examined as secondary endpoints.  128 
Numerical results included in the tables below follow the format: mean ± standard 129 
deviation. Percentages, when relevant, are enclosed in parentheses.  130 
Results 131 
All 21 patients underwent TIPS creation as a preoperative measure. Patient characteristics 132 
prior to TIPS are shown in Table 1. Pressure measurements were recorded during the procedure 133 
for all but one patient (due to equipment failure). These values can be seen in Table 2. The mean 134 
portosystemic gradient prior to TIPS was 14.3 mmHg; this was reduced to a mean of 4.9 mmHg 135 
after TIPS creation.  136 
Hepatic encephalopathy was increased in the cohort following TIPS insertion, with 7 137 
patients (33.3%) experiencing new-onset symptoms within 30 days of the procedure. Thirty-day 138 
mortality after TIPS was 9.5%. One patient died as a result of a transfusion related acute lung 139 
injury three days after TIPS. The second patient died 16 days after TIPS from sepsis secondary 140 
to complications of advanced sigmoid colon carcinoma. Neither death was directly attributable to 141 
the TIPS procedure itself. 142 
After a median follow-up time of 705 days, 11 of the 21 patients who underwent TIPS 143 
creation had undergone the planned abdominal operation. Mean time between TIPS and 144 
operation was 38.7 days (range= 0-156 days). There were no deaths within 30 days of the 145 
abdominal operation. One patient (9.1%) had major perioperative morbidity related to portal 146 
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hypertension and presented with wound dehiscence and infection (felt to be secondary to ascites) 147 
following hernia repair.  148 
Ten of the original 21 patients had not undergone the planned abdominal operation by the 149 
median follow-up time of 705 days. Two of these patients died within 30 days of TIPS creation, 150 
as mentioned previously. Two other patients that had TIPS placement for ascites reduction prior 151 
to hernia repair did not proceed to the planned operation due to resolution of hernia symptoms 152 
after the ascites resolved.  153 
After TIPS, one patient had persistent hepatic encephalopathy requiring multiple 154 
hospitalizations. This required a downsize of the TIPS, which unfortunately lead to recurrence of 155 
the ascites. As a consequence, the patient was never able to be optimized for hernia repair.  156 
Another patient was found to have multiple myeloma after TIPS creation and was no 157 
longer considered a candidate for the initially planned surgery. One patient lived several hours 158 
from the medical center and did not undergo operation due to documented transportation 159 
concerns. In three cases it was unknown why the patient failed to undergo the planned operation. 160 
Discussion 161 
Cirrhotic patients with portal hypertension present a unique challenge and often have 162 
comorbidities that complicate management. Operative intervention in this population has been 163 
associated with higher incidence of hemorrhage, wound dehiscence, infection, and renal 164 
dysfunction [9]. TIPS creation has been used as a method to improve surgical candidacy via 165 
portal decompression but data regarding the risks and benefits of that intervention are limited. 166 
Only a few studies have examined the effects of preoperative TIPS placement. Vinet et 167 
al. found no benefit to preoperative TIPS placement when comparing a group of 18 patients who 168 
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underwent TIPS to a group of 17 matched controls. It is possible that this was an anomaly, 169 
however, because the patients undergoing TIPS were generally more ill and had higher baseline 170 
Child-Pugh scores [7]. Fares et al. indicated a benefit with preoperative TIPS placement in a 171 
retrospective study involving 28 patients. Of the 28 patients with dedicated preoperative TIPS 172 
placement, 24 were able to undergo the planned operation with a thirty-day mortality of 0% and 173 
a one-year mortality of 22% [6]. 174 
Eleven of the 21 patients (52.4%) in this study proceeded to the planned abdominal 175 
operation after undergoing preoperative TIPS creation. This is lower than the completion rate 176 
observed by Fares et al. (86%) but this could be explained by differences in the patient 177 
population. Our study included a significant number of patients with non-alcoholic 178 
steatohepatitis (NASH) as the cause of liver disease, while the vast majority (93%) of patients in 179 
the Fares et al. study had liver disease related to alcohol use or viral hepatitis [6]. Since NASH 180 
has a strong association with obesity, type 2 diabetes mellitus, hypertension, and hyperlipidemia 181 
it is possible that our patient population was already less fit to undergo operation [10].  182 
Currently, both Child-Pugh and MELD scores are used in the preoperative evaluation of 183 
cirrhotic patients, since they have been shown to predict operative mortality. One frequently 184 
cited statistic regarding Child-Pugh scores is that patients in classes A, B, and C have operative 185 
mortality rates of 10%, 30%, and 76%, respectively, when undergoing major abdominal 186 
operation [11]. Although these figures have withstood the test of time and are consistent across 187 
studies, they are not particularly descriptive since each Child-Pugh class encompasses several 188 
different scores. The mean Child-Pugh score for patients undergoing abdominal operation in our 189 
cohort was 7.3, which is included in the range for Child-Pugh class B (scores of 7-9). However, 190 
it is unlikely that the operative mortality in these patients would be predicted to be as high as 191 
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30%, since 7.3 represents the low side of that range. MELD scores are another important 192 
predictor of 30-day operative mortality in cirrhotic patients. In a large retrospective study, 193 
MELD score of 8-11 predicted a 30-day operative mortality rate of 10.3%, while scores of 12-15 194 
predicted a 30-day operative mortality rate of 25.4% [12]. When applying these rules to a group 195 
of patients, one encounters the same difficulties that occur with using Child-Pugh classes to 196 
predict operative mortality; namely that these percentages describe ranges and not individual 197 
scores. A simple heuristic described by Northup et. al is that each 1-point increase in the MELD 198 
score up to 20 points corresponds to a 1% increase in 30-day operative mortality rate [3]. For the 199 
patients in our cohort that underwent abdominal operation, the mean MELD score was 11.7, 200 
which would predict a 30-day operative mortality rate of approximately 11.7%.  201 
One of the most common complications following TIPS creation is the development of 202 
hepatic encephalopathy (HE). The incidence of HE after TIPS is reported to be between 25-45%, 203 
although if only new and worsening cases of HE are considered this range drops to 13-36% [13]. 204 
Since many patients with severe liver disease have some symptoms of encephalopathy at 205 
baseline, this can be a difficult problem to quantify. Within 30 days of TIPS creation, 7 patients 206 
(33.3%) in this cohort experienced new-onset HE. Patients that developed HE more than thirty 207 
days after TIPS were not included in this calculation because of the difficulty in assessing 208 
whether the HE was due to TIPS creation or overall worsening of hepatic function. It is worth 209 
noting that only one patient in this cohort experienced severe, refractory HE that required TIPS 210 
downsizing. The remainder of the patients were able to be managed with medical therapy which 211 
largely consisted of lactulose, rifaximin, and zinc. 212 
One of the 11 patients undergoing abdominal operation experienced grade IIIa 213 
postoperative complications related to portal hypertension as defined by the Clavien-Dindo 214 
Preoperative TIPS 10 
classification system [14]. This patient originally underwent preoperative TIPS to decrease 215 
ascites prior to hernia repair but experienced recurrent ascites, wound dehiscence, and infection 216 
in the postoperative period. This was unexpected since this patient had a portosystemic gradient 217 
pressure of 3 mmHg after TIPS. This eventually required drain placement and antibiotic therapy. 218 
Reasons for failure to undergo the planned abdominal operation were diverse and 219 
multifactorial. While 10 of the 21 patients (47.6%) did not undergo the planned abdominal 220 
operation, it is worth noting that two of these patients no longer required surgical intervention 221 
because of the TIPS creation. Both of these patients underwent TIPS creation in preparation for 222 
hernia operation and had resolution of their hernia symptoms due to the decrease in ascites 223 
following TIPS. Resolution of hernia symptoms following TIPS is a somewhat unexpected 224 
finding since hernia incarceration and complications have been a reported outcome of TIPS [15]. 225 
Because all of the patients underwent TIPS specifically to improve their candidacy for a planned 226 
operation, it was surprising that reasons for failure could not be found for three patients. 227 
Additionally, another patient did not undergo the planned operation due to concerns regarding 228 
transportation. These outcomes highlight both the difficulty and importance of selecting patients 229 
who are likely to complete and benefit from this two-step process.  230 
The main limitation of this study is its retrospective nature. This limits the ability 231 
to collect a more robust data set to allow for more in-depth analysis. Another limitation is the 232 
relatively small size of the series with only 22 patients undergoing preoperative TIPS creation 233 
during this time frame. Lastly, the authors recognize that a comparative arm of patients who 234 
underwent surgery without TIPS creation would be ideal. However, the patients in this series 235 
were not surgical candidates prior to the TIPS creation so no such comparative arm exists as all 236 
patients with these demographics required TIPS creation prior to operation. 237 
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Conclusion 238 
In our population, TIPS creation allowed successful abdominal operation in the majority 239 
of patients, with thirty-day post-TIPS mortality of 9.5%, no thirty-day operative mortality, and 240 
9.1% major postoperative morbidity related to portal hypertension.  241 
242 
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Tables 304 
 Table 1. Patient characteristics prior to TIPS (n=21) 305 
Age in years 56.4 ± 8.8 
Sex 
     Male 
     Female 
13 (61.9) 
8 (38.1) 
Liver disease etiology 
     Non-alcoholic steatohepatitis (NASH) 
     Alcohol 
     Hepatitis C virus 
     Autoimmune hepatitis 
     Primary biliary cirrhosis 
9 (42.8) 
6 (28.6) 
4 (19.0) 
1 (4.8) 
1 (4.8) 
Child-Pugh class 
     A 
     B 
     C 
8 (38.1) 
12 (57.1) 
1 (4.8) 
Child-Pugh score 7.2 ± 1.5 
MELD score 12.0 ± 3.7 
MELD-Na score 11.9 ± 4.3 
Varices 18 (85.7) 
Preoperative TIPS 14 
History of variceal bleeding 5 (23.8) 
History of ascites 13 (61.9) 
Ascites present at time of TIPS 11 (52.4) 
History of encephalopathy 7 (33.3) 
Uncontrolled encephalopathy present at time 
of TIPS 
0 (0.0) 
Beta-blocker in use 9 (42.9) 
WBC 5.2 ± 2.5 
Hemoglobin 11.7 ± 2.0 
Platelets 126.5 ± 70.5 
INR 1.3 ± 0.2 
Prothrombin time 14.2 ± 2.5 
Sodium 135.9 ± 3.0 
Creatinine 1.4 ± 1.6 
Total bilirubin 1.0 ± .6 
ALT 24.1 ± 11.0 
Alkaline phosphatase 87.8 ± 25.7 
Albumin 3.7 ± 1.1 
306 
Table 2. Outcomes of TIPS and pressure measurements in mmHg (n=20) 307 
Pre-TIPS 
      Portosystemic gradient 14.3 ± 4.6 
Preoperative TIPS 15 
Post-TIPS 
   Portosystemic gradient 4.9 ± 1.7 
Hepatic encephalopathy (new-onset) 7 (33.3) 
30-day mortality 2 (9.5) 
308 
